Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$16K
-0.5% from 2023
Prescriptions
129
$123.30 per claim
Patients
88
48 prescribers
Total spending, 2024
$16K
$180.74 per patient
Medicare prescription drug plans paid $16K for Pediarix in 2024, for 129 prescriptions and refills to 88 patients (down 0.5% from 2023). The average cost per claim was $123.30.
Kentucky had the highest Medicare cost for Pediarix in 2024: $5,064 for 47 claims, followed by Wisconsin ($4,443).
Chaitanya Iragavarapu, hematology-oncology in Lexington, KY, had the highest Medicare cost for Pediarix in 2024: 16 claims costing $1,730.
Pediarix is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Chaitanya Iragavarapu Lexington, KY | Hematology-Oncology | 16 | Under 11 | $1,730 |
| Syed Abutalib Milwaukee, WI | Hematology-Oncology | 13 | Under 11 | $1,347 |
| Syed N Haider |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 45 | 98 | 63 | $11K |
| 2023 | 59 | 128 | 90 | $16K |
| 2024 | 48 | 129 | 88 | $16K |
Spending by manufacturer as listed in the spending data
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 12 |
| 11 |
| $1,271 |
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 129 | $16K |